^
    1year
    The Idyllaâ„¢ MSI Test (IVD): An Automated PCR-Based System for the Determination of MSI Status as an Aid for Identification of Probable Lynch Syndrome in Colorectal Cancer Patients (AMP 2023)
    The Idylla MSI Test is a clinically valid method for dMMR screening in CRC patients, and results of this testing can be used to guide further evaluation of individuals for Lynch syndrome. All percentage agreement point estimates used to determine the success of the study exceeded the 90% benchmark established a priori.
    Clinical
    |
    MSI (Microsatellite instability)
    |
    MSI-H/dMMR
    |
    Ventana MMR RxDx Panel • Idylla™ MSI Test • OncoMate™ MSI • TumorNext-Lynch